C Reisner
Overview
Explore the profile of C Reisner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
66
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kelly H, Ahrens R, Holmes M, Stevens A, Vandermeer A, Garris T, et al.
Ann Allergy Asthma Immunol
. 2002 Jan;
87(6):482-7.
PMID: 11770695
Background: Administration of inhaled medications to very young children is sometimes difficult. Administration of inhaled medications via metered dose inhalers (MDIs) to pediatric patients younger than 4 years of age...
2.
Ferry P, Reisner C, Ashpole R
Hosp Med
. 2001 Aug;
62(7):436-7.
PMID: 11480136
No abstract available.
3.
Reisner C, Katial R, Bartelson B, Buchmeir A, Rosenwasser L, Nelson H
Ann Allergy Asthma Immunol
. 2001 May;
86(5):566-74.
PMID: 11379809
Objectives: Different commercially available nebulizers and compressors are available. However, the optimal combination for drug delivery is unknown. Methods: Flow rates of five different compressors (n = 3/compressor) tested alone...
4.
Lumry W, Noveck R, Weinstein S, Barnhart F, Vandermeer A, Murray A, et al.
Ann Allergy Asthma Immunol
. 2001 Apr;
86(3):297-303.
PMID: 11289328
Background: Environmental imperatives to eliminate the use of chlorofluorocarbon (CFC) propellants in metered-dose inhalers have led to the development of metered-dose inhalers with the hydrofluoroalkane (HFA-134a) propellants. Objectives: To evaluate...
5.
Shapiro G, Bronsky E, Murray A, Barnhart F, Vandermeer A, Reisner C
Arch Pediatr Adolesc Med
. 2000 Dec;
154(12):1219-25.
PMID: 11115306
Background: Aerosolized asthma medications with chlorofluorocarbon (CFC) propellants are being phased out because of environmental concerns about the ozone layer. Medications are being reformulated with non-ozone-depleting propellants. Objective: To evaluate...
6.
Katial R, Reisner C, Buchmeier A, Bartelson B, Nelson H
Ann Allergy Asthma Immunol
. 2000 Mar;
84(2):255-61.
PMID: 10719784
Background: The clinical acceptance of the initial ultrasonic nebulizers was impeded by their production of significant quantities of droplets larger than the respirable range that could have resulted in poor...
7.
Dorinsky P, Reisner C, Ferguson G, Menjoge S, Serby C, Witek Jr T
Chest
. 1999 Apr;
115(4):966-71.
PMID: 10208193
Study Objectives: To determine whether the combination of ipratropium bromide and albuterol results in greater and more consistent pulmonary function test (PFT) response rates than ipratropium bromide or albuterol alone...
8.
Van Andel A, Reisner C, Menjoge S, Witek T
Chest
. 1999 Mar;
115(3):703-7.
PMID: 10084479
Study Objective: To document temporal usage trends for commonly used respiratory medications in patients with COPD. Design: We retrospectively evaluated baseline concomitant medications of 3,720 patients with COPD enrolled in...
9.
Reisner C, Nelson H
J Allergy Clin Immunol
. 1997 Jun;
99(6 Pt 1):843-6.
PMID: 9215254
No abstract available.
10.
Reisner C, Mason 3rd U
Ann Intern Med
. 1997 Apr;
126(8):662-3; author reply 663-4.
PMID: 9103143
No abstract available.